Kymera Therapeutics, Inc. logo KYMR - Kymera Therapeutics, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 23
HOLD 3
SELL 0
STRONG
SELL
0
| PRICE TARGET: $119.93 DETAILS
HIGH: $138.00
LOW: $106.00
MEDIAN: $119.00
CONSENSUS: $119.93
UPSIDE: 52.02%
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4 2019 Q3
Revenue
Revenue 34.4 2.9 2.8 11.5 22.1 7.4 3.7 25.6 10.3 47.9 4.7 16.5 9.5 16.1 9.6 11.5 9.6 15.3 20.3 18.5 18.7 12.8 14.5 3.3 3.4 1.8 0.9
Cost of Revenue 0 (76.2) 74.1 2.1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Gross Profit 34.4 79.0 (71.3) 9.4 22.1 7.4 3.7 25.6 10.3 47.9 4.7 16.5 9.5 16.1 9.6 11.5 9.6 15.3 20.3 18.5 18.7 12.8 14.5 3.3 3.4 1.8 0.9
Operating Expenses
R&D Expenses 98.2 83.9 74.1 78.4 80.3 71.8 60.4 59.2 48.8 53.0 48.1 45.8 42.2 43.1 43.9 41.3 35.9 37.5 38.3 35.2 26.0 20.4 15.8 13.8 12.1 11.1 11.3
SG&A Expenses 20.4 16.9 17.3 17.6 16.3 16.3 15.5 17.4 14.4 14.2 14.1 14.1 12.6 11.6 10.6 11.0 10.6 11.7 10.7 8.0 5.9 5.2 6.8 3.7 2.6 2.5 1.5
Other Expenses 0 76.1 (70.2) (2.1) 0 0 0 0 4.9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Operating Expenses 118.5 176.9 21.2 93.9 96.5 88.1 75.9 76.6 68.1 67.2 62.2 59.9 54.8 54.8 54.4 52.3 46.6 49.3 49.0 43.2 31.9 25.6 22.6 17.5 14.7 13.6 12.8
Operating Income
Operating Income (84.2) (97.9) (92.5) (84.6) (74.4) (80.8) (72.1) (50.9) (57.8) (19.3) (57.5) (43.4) (45.3) (38.6) (44.9) (40.8) (36.9) (34.0) (28.6) (24.7) (13.2) (12.8) (8.1) (14.2) (11.2) (11.8) (11.9)
Interest Expense 0.1 0.1 0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Interest Income 15.0 10.7 10.3 8.1 8.9 10.1 9.7 8.9 9.3 5.0 4.7 4.6 4.5 3.8 1.9 0.6 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.3 0.3 0.4
Profitability
EBITDA (67.2) (85.2) (79.3) (74.4) (63.5) (68.7) (60.4) (40.1) (47.0) (13.5) (51.9) (37.9) (40.0) (34.0) (42.2) (39.5) (36.0) (33.2) (27.8) (24.1) (12.6) (12.2) (7.5) (13.6) (10.5) (11.1) (11.3)
EBIT (69.2) (87.2) (82.2) (76.5) (65.5) (70.7) (62.4) (42.0) (48.5) (14.3) (52.8) (38.8) (40.9) (34.8) (43.0) (40.2) (36.6) (33.8) (28.5) (24.6) (13.1) (12.7) (8.0) (14.0) (10.9) (11.5) (11.4)
Income Before Tax (69.2) (87.3) (82.2) (76.6) (65.6) (70.8) (62.5) (42.1) (48.6) (14.4) (52.9) (38.8) (40.9) (34.9) (43.0) (40.3) (36.7) (33.9) (28.6) (24.7) (13.1) (12.7) (8.0) (14.0) (10.9) (11.5) (11.4)
Income Tax Expense 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Net Income (69.2) (87.0) (82.2) (76.6) (65.6) (70.8) (62.5) (42.1) (48.6) (14.4) (52.9) (38.8) (40.9) (34.9) (43.0) (40.3) (36.7) (33.9) (28.6) (24.7) (13.1) (12.7) (8.0) (14.0) (10.9) (11.5) (11.4)
Per Share Data
EPS (Basic) -0.71 -0.98 -0.94 -0.95 -0.82 -0.88 -0.82 -0.58 -0.69 -0.25 -0.90 -0.67 -0.63 -0.59 -0.79 -0.77 -0.71 -0.66 -0.56 -0.55 -0.29 -0.29 -0.18 -0.32 -0.25 -0.26 -0.26
EPS (Diluted) -0.71 -0.98 -0.94 -0.95 -0.82 -0.88 -0.82 -0.58 -0.69 -0.25 -0.90 -0.67 -0.63 -0.59 -0.79 -0.77 -0.71 -0.66 -0.56 -0.55 -0.29 -0.29 -0.18 -0.32 -0.25 -0.26 -0.26
Shares Outstanding 97.5 84.4 87.3 80.4 80.1 80.0 76.1 73.1 70.8 58.5 58.4 58.3 58.2 57.9 54.5 51.8 51.7 51.4 50.7 45.1 44.6 44.5 43.8 43.1 44.5 44.5 44.5
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2019 Q4
Current Assets
Cash & Cash Equivalents 144.1 357.0 112.9 335.8 90.0 120.3 110.7 67.6 93.5 110.0 81.1 52.4 50.2 68.4 155.7 76.9 33.7 48.0 156.8 84.9 53.1 31.0 54.6 61.0 76.0
Short-Term Investments 506.8 491.3 392.7 329.6 373.2 368.5 439.3 442.3 427.0 264.9 276.8 315.2 346.7 338.8 326.2 315.4 387.1 394.4 379.6 274.2 280.4 265.2 239.2 95.0 15.9
Net Receivables 0 0 0 40 20 0.9 1.3 1.7 2.0 18.8 3.8 4.1 3.3 2.5 2.9 2.4 1.3 0.1 1.6 0.9 1.7 1.4 0.6 0 0
Inventory 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Assets 26.5 22.9 22.6 22.9 17.8 20.6 17.4 13.8 14.7 11.7 14.1 13.7 11.4 9.7 0 0 0 0 0 0 0 0 0 0 0
Total Current Assets 677.4 871.2 528.3 728.3 501.0 510.3 568.7 525.4 537.3 405.3 375.7 385.4 411.6 419.4 494.0 402.8 431.4 451.3 543.7 364.8 340.8 302.3 297.4 158.3 92.8
Non-Current Assets
Property, Plant & Equipment 83.4 85.5 88.1 94.6 95.9 97.9 99.3 100.4 98.7 101.1 91.1 83.2 74.0 22.2 21.6 21.9 21.1 21.3 21.7 21.8 20.5 20.7 20.9 20.3 22.1
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Long-Term Investments 894.7 777.0 478.8 303.4 312.3 362.2 361.0 192.4 224.4 61.4 77.0 104.8 119.0 152.3 113.7 90.2 102.5 125.2 74.7 45.3 101.6 162.5 187.5 0 0
Other Non-Current Assets 13.5 9.1 6.8 4.7 9.1 7.7 5.8 7.7 7.9 7.9 8.6 8.6 9.3 9.1 9.1 8.5 8.1 8.1 2.3 2.5 1.6 1.6 1.6 2.5 1.8
Total Non-Current Assets 991.6 871.6 573.7 402.7 417.4 467.8 466.1 300.6 331.0 170.4 176.7 196.5 202.4 183.7 144.4 120.7 131.7 154.6 98.7 69.6 123.8 184.8 210.0 22.8 23.9
Total Assets 1,669.0 1,742.8 1,102.0 1,131.1 918.3 978.0 1,034.8 826.0 868.3 575.8 552.4 581.9 613.9 603.1 638.5 523.4 563.1 605.9 642.5 434.4 464.6 487.2 507.4 181.1 116.7
Current Liabilities
Account Payables 12.8 4.0 5.5 5.8 10.3 6.0 6.5 6.5 6.8 7.1 5.0 3.7 6.5 4.3 6.3 2.4 2.6 4.0 5.0 8.2 8.3 4.4 4.0 4.0 3.3
Short-Term Debt 0 13.8 13.7 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Deferred Revenue 0 22.9 23.3 40 11.5 13.6 20.0 19.3 22.6 37.9 27.4 24.3 32.2 35.3 55.8 59.5 60.9 61.7 66.2 82.3 87.9 92.6 92.0 27.3 23.3
Other Current Liabilities 36.1 24.2 17.3 20.6 0.9 0.2 17.6 0.2 0.8 0.5 0.9 0.3 0.8 0.3 0.7 0.3 0.6 0.2 0.4 0.1 0.3 0.1 0.7 0 0
Total Current Liabilities 62.6 83.2 71.6 87.5 59.0 67.8 66.5 62.1 56.1 85.7 63.2 54.6 61.9 71.3 91.1 87.5 88.3 92.5 94.5 108.7 110.1 110.6 107.3 42.7 34.6
Non-Current Liabilities
Long-Term Debt 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Deferred Tax Liabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0 0.0 0.2 0.2 0.2 0.3 0.3 0.3 0.1 0.1 0.1 0.1 0.1 0 0 109.1
Total Non-Current Liabilities 66.7 79.9 84.2 72.0 73.1 74.6 75.4 79.0 100.9 95.1 93.7 91.9 90.0 41.6 34.5 38.0 46.0 53.7 64.8 67.6 79.2 92.7 105.4 34.4 156.5
Total Liabilities 129.4 163.1 155.8 159.6 132.1 142.4 141.9 141.1 157.0 180.8 156.8 146.5 151.9 113.0 125.6 125.5 134.3 146.3 159.3 176.3 189.3 203.3 212.7 77.1 191.1
Stockholders' Equity
Common Stock 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0
Retained Earnings (1,135.2) (1,066.0) (979.0) (896.8) (820.2) (754.6) (683.9) (621.4) (579.3) (530.8) (516.4) (463.5) (424.7) (383.8) (348.9) (305.9) (265.7) (229.0) (195.1) (166.5) (141.8) (128.8) (116.1) (108.1) (76.5)
Accumulated Other Comprehensive Income (4.2) 1.8 1.5 0.3 (0.1) (1.5) 1.9 (2.1) (1.8) (0.6) (2.5) (3.6) (3.0) (4.9) (5.9) (4.0) (3.2) (0.7) (0.1) 0 (0.0) (0.1) (0.2) 0.0 0.0
Total Stockholders' Equity 1,539.6 1,579.7 946.3 971.5 786.2 835.6 892.9 684.9 711.2 395.0 395.5 435.4 462.0 490.2 512.9 398.0 428.7 459.6 483.1 258.1 275.2 283.9 294.7 104.0 (74.4)
Total Liabilities & Equity 1,669.0 1,742.8 1,102.0 1,131.1 918.3 978.0 1,034.8 826.0 868.3 575.8 552.4 581.9 613.9 603.1 638.5 523.4 563.1 605.9 642.5 434.4 464.6 487.2 507.4 181.1 116.7
Debt Metrics
Total Debt 80.5 82.3 84.0 85.7 86.3 87.8 88.2 88.2 87.0 84.7 80.8 75.1 68.8 17.3 16.7 17.3 17.5 18.0 18.4 18.3 17.5 18.0 17.8 19.1 21.2
Net Debt (63.6) (274.8) (29.0) (250.1) (3.6) (32.5) (22.5) 20.6 (6.5) (25.3) (0.2) 22.7 18.6 (51.1) (138.9) (59.6) (16.3) (30.0) (138.4) (66.6) (35.6) (13.0) (36.8) (41.9) (54.8)
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4 2019 Q3
Operating Activities
Net Income (69.2) (87.0) (82.2) (76.6) (65.6) (70.8) (62.5) (42.1) (48.6) (14.4) (52.9) (38.8) (40.9) (34.9) (43.0) (40.3) (36.7) (33.9) (28.6) (24.7) (13.1) (12.7) (8.0) (14.0) (10.9) (11.5) (11.4)
Depreciation & Amortization 2.0 2.0 2.1 2.1 2.0 2.0 2.0 1.9 1.5 0.9 0.9 0.9 0.9 0.8 0.8 0.7 0.7 0.7 0.7 0.6 0.5 0.5 0.5 0.4 0.4 0.4 0.2
Stock-Based Compensation 16.0 14.5 15.8 15.4 14.2 13.8 14.9 14.3 12.0 10.9 11.7 11.2 9.4 8.9 9.1 9.6 7.9 8.7 7.4 5.7 3.2 1.8 2.3 0.7 0.4 0.3 0.2
Change in Working Capital (34.9) 5.8 38.5 1.4 (27.3) 3.4 1.4 10.8 1.9 (0.5) 9.8 8.0 (8.1) 2.2 1.4 (0.2) (13.3) (15.5) (18.4) (13.4) (14.7) (11.3) 136.7 1.4 (2.0) (0.1) (1.6)
Other Non-Cash Items (2.7) (2.0) (1.4) (2.1) (2.5) (10.2) (6.0) (27.9) (6.3) 11.1 (1.1) (16.5) (5.3) (16.6) (2.6) (8.9) 1.2 1.6 1.7 1.2 1.3 1.6 0.1 0.1 0.1 0.1 0.1
Operating Cash Flow (88.8) (66.7) (27.1) (59.9) (79.2) (61.8) (50.2) (42.9) (39.6) 8.0 (31.6) (35.3) (44.0) (39.5) (34.3) (39.0) (40.3) (38.4) (37.3) (30.5) (22.8) (20.1) 131.7 (11.4) (12.1) (10.8) (12.5)
Investing Activities
Capital Expenditure (0.4) (0.1) (0.2) (0.7) (0.5) (0.9) 0.2 (4.7) (7.4) (11.6) (8.1) (10.8) (4.0) (0.4) (1.2) (0.7) (0.5) (0.5) (0.3) (0.6) (0.2) (1.4) (2.4) (3.9) (1.4) (0.2) (0.2)
Acquisitions 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1.2 5.8 0 0 1.3 0 0 0 0 0 0
Purchases of Investments (276.3) (498.2) 0 (58.3) (83.7) 0 0 0 0 0 0 0 0 0 0 0 (80.1) (164.4) (245.8) (30.2) (16.0) (68.4) (350.4) (74.5) (36.0) 62.2 (78.1)
Sales/Maturities of Investments 131.1 101.8 0 116.8 130.2 0 0 0 0 0 0 0 0 0 0 0 106.5 96.9 109.3 91.5 60.5 65.9 18.5 31.5 0 0 0
Other Investing Activities 2.7 2.0 (235.1) 2.1 2.5 69.5 (157.9) 20.3 (323.2) 30.6 68.6 46.6 28.6 (49.3) (36.2) 82.5 (1.2) (5.8) 0 0 (1.3) 0 0 0 0 0 0
Investing Cash Flow (142.8) (394.4) (235.3) 60.0 48.6 68.6 (157.7) 15.6 (330.6) 19.0 60.5 35.8 24.6 (49.7) (37.5) 81.8 25.9 (68.0) (136.9) 60.7 44.3 (4.0) (334.3) (46.9) (37.4) 62.0 (78.3)
Financing Activities
Net Debt Issuance (0.4) (0.4) (0.4) (0.4) (0.3) (0.3) (0.6) (0.4) (0.3) 0.9 (0.3) (0.3) (0.3) (0.3) (0.3) (0.3) (0.3) (0.2) (0.4) (0.2) (0.2) (0.2) (0.1) (0.2) (0.1) (0.1) (0.1)
Stock Repurchased 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 0 0 39.9 0 0 3.1 251.6 1.8 354.0 1.0 0.1 1.6 1.5 2.3 150.8 0.6 0.4 2.2 246.4 1.8 0.8 0.0 196.4 0.0 0 0.0 0.0
Financing Cash Flow 18.8 705.2 39.5 245.7 0.3 2.8 250.9 1.4 353.8 1.9 (0.2) 1.3 1.2 2.0 150.5 0.4 0.2 2.1 246.0 1.6 0.6 0.3 196.3 (0.4) 93.1 21.1 (0.0)
Cash Position
Net Change in Cash (212.9) 244.1 (222.9) 245.9 (30.3) 9.5 43.0 (25.9) (16.4) 28.9 28.7 1.9 (18.2) (87.2) 78.7 43.2 (14.2) (104.3) 71.9 31.8 22.1 (23.8) (6.4) (58.7) 43.7 72.3 (90.8)
Cash at Beginning 362.8 118.7 341.6 95.8 126.0 116.5 73.5 99.3 115.8 86.8 58.2 56.3 74.5 161.8 83.0 39.8 54.1 158.4 86.5 54.7 32.6 56.4 62.8 121.4 77.8 5.5 96.4
Cash at End 149.9 362.8 118.7 341.6 95.8 126.0 116.5 73.5 99.3 115.8 86.8 58.2 56.3 74.5 161.8 83.0 39.8 54.1 158.4 86.5 54.7 32.6 56.4 62.8 121.4 77.8 5.5
Free Cash Flow (89.3) (66.9) (27.3) (60.6) (79.6) (62.7) (50.0) (47.6) (47.0) (3.6) (39.7) (46.0) (48.0) (39.9) (35.5) (39.7) (40.8) (38.9) (37.6) (31.1) (23.0) (21.5) 129.3 (15.3) (13.5) (11) (12.7)
Key Metrics 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4 2019 Q3
Income Statement
Revenue 34.4 2.9 2.8 11.5 22.1 7.4 3.7 25.6 10.3 47.9 4.7 16.5 9.5 16.1 9.6 11.5 9.6 15.3 20.3 18.5 18.7 12.8 14.5 3.3 3.4 1.8 0.9
Gross Profit 34.4 79.0 (71.3) 9.4 22.1 7.4 3.7 25.6 10.3 47.9 4.7 16.5 9.5 16.1 9.6 11.5 9.6 15.3 20.3 18.5 18.7 12.8 14.5 3.3 3.4 1.8 0.9
Operating Income (84.2) (97.9) (92.5) (84.6) (74.4) (80.8) (72.1) (50.9) (57.8) (19.3) (57.5) (43.4) (45.3) (38.6) (44.9) (40.8) (36.9) (34.0) (28.6) (24.7) (13.2) (12.8) (8.1) (14.2) (11.2) (11.8) (11.9)
Net Income (69.2) (87.0) (82.2) (76.6) (65.6) (70.8) (62.5) (42.1) (48.6) (14.4) (52.9) (38.8) (40.9) (34.9) (43.0) (40.3) (36.7) (33.9) (28.6) (24.7) (13.1) (12.7) (8.0) (14.0) (10.9) (11.5) (11.4)
EPS (Diluted) -0.71 -0.98 -0.94 -0.95 -0.82 -0.88 -0.82 -0.58 -0.69 -0.25 -0.90 -0.67 -0.63 -0.59 -0.79 -0.77 -0.71 -0.66 -0.56 -0.55 -0.29 -0.29 -0.18 -0.32 -0.25 -0.26 -0.26
Balance Sheet
Cash & Equivalents 144.1 357.0 112.9 335.8 90.0 120.3 110.7 67.6 93.5 110.0 81.1 52.4 50.2 68.4 155.7 76.9 33.7 48.0 156.8 84.9 53.1 31.0 54.6 61.0 76.0
Total Assets 1,669.0 1,742.8 1,102.0 1,131.1 918.3 978.0 1,034.8 826.0 868.3 575.8 552.4 581.9 613.9 603.1 638.5 523.4 563.1 605.9 642.5 434.4 464.6 487.2 507.4 181.1 116.7
Total Debt 80.5 82.3 84.0 85.7 86.3 87.8 88.2 88.2 87.0 84.7 80.8 75.1 68.8 17.3 16.7 17.3 17.5 18.0 18.4 18.3 17.5 18.0 17.8 19.1 21.2
Stockholders' Equity 1,539.6 1,579.7 946.3 971.5 786.2 835.6 892.9 684.9 711.2 395.0 395.5 435.4 462.0 490.2 512.9 398.0 428.7 459.6 483.1 258.1 275.2 283.9 294.7 104.0 (74.4)
Cash Flow
Operating Cash Flow (88.8) (66.7) (27.1) (59.9) (79.2) (61.8) (50.2) (42.9) (39.6) 8.0 (31.6) (35.3) (44.0) (39.5) (34.3) (39.0) (40.3) (38.4) (37.3) (30.5) (22.8) (20.1) 131.7 (11.4) (12.1) (10.8) (12.5)
Capital Expenditure (0.4) (0.1) (0.2) (0.7) (0.5) (0.9) 0.2 (4.7) (7.4) (11.6) (8.1) (10.8) (4.0) (0.4) (1.2) (0.7) (0.5) (0.5) (0.3) (0.6) (0.2) (1.4) (2.4) (3.9) (1.4) (0.2) (0.2)
Free Cash Flow (89.3) (66.9) (27.3) (60.6) (79.6) (62.7) (50.0) (47.6) (47.0) (3.6) (39.7) (46.0) (48.0) (39.9) (35.5) (39.7) (40.8) (38.9) (37.6) (31.1) (23.0) (21.5) 129.3 (15.3) (13.5) (11) (12.7)